Blue Industries Inc. Admits Infringement of CARTIS' Patent.

Business Editors

PALM BEACH, Fla.--(BUSINESS WIRE)--Feb. 19, 2003

CARTIS Inc. (the Company) (Pink Sheets:CARI) is delighted with the press release of Feb. 14, 2003, of Blue Industries Inc. (BLUE) (OTCBB:BLIIV) acknowledging the cancellation of all contractual relationships it had with the Company.

In the press release, however, BLUE admits that "it has developed proprietary technology for the production of its FS600x filtration powder." This, of course, was developed, by the own admission of BLUE's President, Mr. Patrick Gouverneur, while BLUE was under an exclusive contract with CARTIS Inc. and at a time when the Corporate Secretary of BLUE, namely Mr. Cyril Heitzler, was the General Manager of CEFCA Sarl, the manufacturer of the Cartis(TM) powder (and 100% subsidiary of CARTIS Inc.) leading to conflicts of interest and unauthorized transfers of technology suspicions. Indeed, how could BLUE "develop its proprietary products in several months," when it took Mr. Herve Gallion several years to develop the Cartis(TM) powder, whilst all other prominent existing leaders of the market were unable to develop the same?

Furthermore, BLUE recognizes that its FS600x powder is "similar to a competitive product manufactured by CARTIS Inc.," but that "the manufacturing process is different." The Cartis(TM) powder's patent not only covers the manufacturing process, but also the powder itself in its broadest interpretation of coverage to the extent that it is protected:

"Any product used for the bactericidal & bacteriostatic treatment of fluids characterized in that it consists almost exclusively, on the one hand, of a porous support with inner and outer specific surface and, on the other hand, of a metal covering said surface in a thin layer substantially uniform over the whole surface, said metal being bound to the porous support by strong bonds. The product is obtainable in a cold plasma reactor."

Let it be noted that the FS600x powder is not patented despite BLUE's misleading statement referring to "patented technologies" in the company's "About Blue" description of activity section.

Regarding the further statement of BLUE's President relative to the superior performance of their FS600x powder in terms of price, quality and availability, we must stress that, of course, if one does not have to consider the cost incurring to 7 years of research, development & testing in its price, such price may possibly turn to be more competitive. With regard to quality, the criteria for better or worse does not apply as if the metal layer covering the porous support is too thick, the bounding is inappropriate and, too thin, it just does not work. Finally for the availability, CARTIS Inc. disposes of sizable stocks and of 9 Plasma reactors to produce the Patented Cartis(TM) powder to meet the demand, with a conservative potential yearly production capacity of 240,000 Liters, unmatched by Blue Industries Inc.

Of course CARTIS Inc. is initiating legal proceeding to stop Blue Industries Inc. wrongdoing.

About CARTIS Inc.

CARTIS Inc. is a Company specialized in the manufacturing, production and distribution of powder cartridges and devices for the treatment of water. The Company commercializes its products under the trademark Cartis(TM).

Safe Harbor statement under the Private Securities Litigation Reform Act of 1955. This release contains forward-looking statements within the meaning of Section 27A of the Securities & Exchange Act of 1933 and section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussion with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical facts may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made to involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.